Literature DB >> 23608880

The origin of deletion 22q11 in chronic lymphocytic leukemia is related to the rearrangement of immunoglobulin lambda light chain locus.

Marek Mraz1, Katerina Stano Kozubik, Karla Plevova, Katerina Musilova, Boris Tichy, Marek Borsky, Petr Kuglik, Michael Doubek, Yvona Brychtova, Jiri Mayer, Sarka Pospisilova.   

Abstract

The technology of array comparative genomic hybridization (array-CGH/aCGH) enabled the identification of novel genomic aberrations in chronic lymphocytic leukemia (CLL) including the monoallelic and biallelic deletions affecting 22q11 locus. In contrast to previous publications, we hypothesized that the described 22q11 deletions are a consequence of the rearrangement of immunoglobulin lambda light chain locus (IGL) segments surrounding several protein-coding genes located in this region. Indeed, using array-CGH and PCR analysis we show that all deletions (n=7) affecting the 22q11 locus in our cohort (n=40) are based on the physiological mechanism of IGL rearrangement. This demonstrates that this loss of genetic material is likely not pathogenic and in fact is merely a marker of IGL rearrangement.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23608880     DOI: 10.1016/j.leukres.2013.03.018

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  9 in total

1.  Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets.

Authors:  Alyssa Bouska; Chengfeng Bi; Waseem Lone; Weiwei Zhang; Ambreen Kedwaii; Tayla Heavican; Cynthia M Lachel; Jiayu Yu; Roberto Ferro; Nanees Eldorghamy; Timothy C Greiner; Julie Vose; Dennis D Weisenburger; Randy D Gascoyne; Andreas Rosenwald; German Ott; Elias Campo; Lisa M Rimsza; Elaine S Jaffe; Rita M Braziel; Reiner Siebert; Rodney R Miles; Sandeep Dave; Anupama Reddy; Jan Delabie; Louis M Staudt; Joo Y Song; Timothy W McKeithan; Kai Fu; Michael Green; Wing C Chan; Javeed Iqbal
Journal:  Blood       Date:  2017-08-11       Impact factor: 22.113

2.  Accumulation of Cytoplasmic DNA Due to ATM Deficiency Activates the Microglial Viral Response System with Neurotoxic Consequences.

Authors:  Xuan Song; Fulin Ma; Karl Herrup
Journal:  J Neurosci       Date:  2019-06-12       Impact factor: 6.167

3.  Genetic mechanism for the loss of PRAME in B cell lymphomas.

Authors:  Marek Mraz
Journal:  J Clin Invest       Date:  2022-07-15       Impact factor: 19.456

4.  Genetic mechanism for the loss of PRAME in B cell lymphomas. Reply.

Authors:  Katsuyoshi Takata; Christian Steidl
Journal:  J Clin Invest       Date:  2022-07-15       Impact factor: 19.456

5.  Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C.

Authors:  Alex J Cornish; Phuc H Hoang; Sara E Dobbins; Philip J Law; Daniel Chubb; Giulia Orlando; Richard S Houlston
Journal:  Blood Adv       Date:  2019-01-08

Review 6.  LncRNAs in adaptive immunity: role in physiological and pathological conditions.

Authors:  Pedro Faria Zeni; Marek Mraz
Journal:  RNA Biol       Date:  2020-11-09       Impact factor: 4.652

7.  Identification of prognostic relevant chromosomal abnormalities in chronic lymphocytic leukemia using microarray-based genomic profiling.

Authors:  Marian Jpl Stevens-Kroef; Eva van den Berg; Daniel Olde Weghuis; Ad Geurts van Kessel; Rolph Pfundt; Matty Linssen-Wiersma; Marloes Benjamins; Trijnie Dijkhuizen; Patricia Jta Groenen; Annet Simons
Journal:  Mol Cytogenet       Date:  2014-01-09       Impact factor: 2.009

8.  Copy number variation analysis on a non-Hodgkin lymphoma case-control study identifies an 11q25 duplication associated with diffuse large B-cell lymphoma.

Authors:  Lucia Conde; Jacques Riby; Jianqing Zhang; Paige M Bracci; Christine F Skibola
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

Review 9.  The Role of Noncoding RNAs in B-Cell Lymphoma.

Authors:  Jingwen Li; Jing Zou; Xiaoyue Wan; Chunyan Sun; Fei Peng; Zhangbo Chu; Yu Hu
Journal:  Front Oncol       Date:  2020-10-23       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.